Grifols SA, Barcelona (GRFS) Receives Average Rating of “Hold” from Brokerages

Grifols SA, Barcelona (NASDAQ:GRFS) has been given a consensus rating of “Hold” by the eight ratings firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, four have given a hold recommendation and three have given a buy recommendation to the company.

Several brokerages have recently commented on GRFS. Zacks Investment Research raised Grifols SA, Barcelona from a “sell” rating to a “hold” rating in a research note on Thursday, January 4th. BidaskClub raised Grifols SA, Barcelona from a “sell” rating to a “hold” rating in a research note on Wednesday, December 27th. UBS Group lowered Grifols SA, Barcelona from an “outperform” rating to a “market perform” rating in a research note on Friday, November 24th. Finally, Citigroup began coverage on Grifols SA, Barcelona in a research note on Tuesday, October 31st. They set a “buy” rating on the stock.

Institutional investors have recently modified their holdings of the stock. FMR LLC raised its position in shares of Grifols SA, Barcelona by 2.7% during the 2nd quarter. FMR LLC now owns 6,523,773 shares of the biotechnology company’s stock worth $137,847,000 after purchasing an additional 171,192 shares during the last quarter. California Public Employees Retirement System raised its position in shares of Grifols SA, Barcelona by 2.2% during the 2nd quarter. California Public Employees Retirement System now owns 414,700 shares of the biotechnology company’s stock worth $8,763,000 after purchasing an additional 9,000 shares during the last quarter. OxFORD Asset Management LLP raised its position in shares of Grifols SA, Barcelona by 37.2% during the 3rd quarter. OxFORD Asset Management LLP now owns 244,401 shares of the biotechnology company’s stock worth $5,342,000 after purchasing an additional 66,208 shares during the last quarter. Verition Fund Management LLC acquired a new position in shares of Grifols SA, Barcelona during the 2nd quarter worth approximately $391,000. Finally, Great West Life Assurance Co. Can raised its position in shares of Grifols SA, Barcelona by 6.6% during the 3rd quarter. Great West Life Assurance Co. Can now owns 445,901 shares of the biotechnology company’s stock worth $9,718,000 after purchasing an additional 27,470 shares during the last quarter. Hedge funds and other institutional investors own 22.50% of the company’s stock.

Shares of Grifols SA, Barcelona (NASDAQ:GRFS) opened at $24.60 on Wednesday. The company has a market capitalization of $6,270.00, a P/E ratio of 25.78, a PEG ratio of 1.60 and a beta of 1.03. The company has a debt-to-equity ratio of 1.69, a quick ratio of 1.39 and a current ratio of 3.17. Grifols SA, Barcelona has a 52 week low of $16.37 and a 52 week high of $24.61.

TRADEMARK VIOLATION NOTICE: “Grifols SA, Barcelona (GRFS) Receives Average Rating of “Hold” from Brokerages” was first published by BBNS and is the property of of BBNS. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. & international copyright law. The original version of this article can be viewed at https://baseballnewssource.com/markets/grifols-sa-barcelona-grfs-receives-average-rating-of-hold-from-brokerages/1821885.html.

Grifols SA, Barcelona Company Profile

Grifols, SA, a specialty pharmaceutical company, develops, manufactures, and distributes biological medicines on plasma derived proteins in the United States, Canada, Spain, rest of the European Union, and internationally. The company specializes in providing infusion solutions, nutrition products, and medical devices for use in hospitals and clinics.

Receive News & Ratings for Grifols SA Barcelona Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grifols SA Barcelona and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Rumor: Milwaukee Brewers Offer Yu Darvish Contract
Rumor: Milwaukee Brewers Offer Yu Darvish Contract
Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Houston Astros Add Starter to Rotation
Houston Astros Add Starter to Rotation
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Justin Morneau Former Star With Twins and AL MVP Retires
Justin Morneau Former Star With Twins and AL MVP Retires


Leave a Reply

 
© 2006-2018 BBNS.